Profiles people listing in a scrolling container.
  1. Home
  2. Person Directory

Nic Mastascusa, PharmD, BCNP

Clinical Assistant Professor

Introduction

-University of Iowa College of Pharmacy 2004-2008, PharmD degree earned

  • Purdue University Department of Pharmacy Practice Nuclear Pharmacy Authorized Nuclear Pharmacist Certificate Program 2008 -Board Certified Nuclear Pharmacist 2017

Current Positions

  • Clinical Assistant Professor of Pharmacy Practice and Science

Education

  • Doctor of Pharmacy in Pharmacy, University of Iowa College of Pharmacy, Iowa City, Iowa

Licenses & Certifications

  • Board Certified Nuclear Pharmacist, BPS, Iowa
  • Authorized Nuclear Pharmacist, Purdue University, Indiana, United States
  • R.Ph., Iowa Board of Pharmacy, Iowa, United States

Selected Awards & Honors

  • Introductory Pharmacy Practice Preceptor of the Year, University of Iowa College of Pharmacy, Iowa City, Iowa

Professional Memberships

  • American Society of Health System Pharmacists (ASHP)
  • American Pharmacists Association (APhA)
  • Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Research Interests

  • Radiation Biology
  • Radiopharmaceuticals and Oncology

Selected Publications

  • Weatherman, K., Grady, E., Mastascusa, N., Johnson, S., Hinkle, G., Laforest, R., Wendorf, C., & Thomas, K. (2025). Practice Guideline for the use of Radiopharmaceuticals 5.0. SNMMI. https://snmmi.org/Web/Clinical-Practice/Procedure-Standards/Standards/Use_of_Radiopharmaceuticals_5
  • Soulek, D., Martin, M., Mastascusa, N. & Graves, S. (2022). Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs. Journal of Nuclear Medicine Technology/Society of Nuclear Medicine and Molecular Imaging 50 (3) 195-202. DOI: https://doi.org/10.2967/jnmt.122.263813. PMID: 35701215.
  • Mastascusa, N. (2020). Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine. Journal of nuclear medicine technology : JNMT. 48 (4) 388-389.
  • Mastascusa, N. & Ponto, J. (2020). Retention of Lu-177 Peptide in Dose Vial and Administration Tubing. (Vols. 60). (3), pp. e135. Iowa City: Journal of American Pharmacists Association.